Pharmaceuticals

Traditional_Medicine_Market.jpg

Traditional Medicine Market Size, Share & Trends Analysis Report By Product (Herbal Medicine, Ayurvedic Medicine, Unani Medicine, Alternative Medicine, Homeopathy Medicine, Others ), By Form (Capsules and Tablets, Powders and Granules, Liquid Extracts, Syrups, Creams and Ointment, Others ), By Disease Indication (Cardiac Disorders, Bone and Joint Disorders, Gynecological Disorders, Neurological and Mental Disorders, Digestive Disorders, Others), By Distribution Channel (Hospital and Retail Pharmacies, Online Pharmacies, Specialty Stores, Direct Sales, By Region, And By Segment Forecasts, 2025-2034

Global Traditional Medicine Market Size is valued at USD 190.95 Bn in 2024 and is predicted to reach USD 426.70 Bn by the year 2034 at a 8.5% CAGR during the forecast period for 2025-2034. Traditional medicine encompasses a variety of health practic...

View Sample PDF

Slide2-min_(1)31.JPG

Pharmacovigilance Market Size, Share & Trends Analysis Report By Service Provider (In-House And Contract Outsourcing), Product Life Cycle (Pre-Clinical, Phase I, Phase II, Phase III And Phase IV), By Type, By Process Flow, By Therapeutic Area, And By End-Use, By Region, And Segment Forecasts, 2025-2034

Global Pharmacovigilance Market Size is valued at USD 7.8 Bn in 2024 and is predicted to reach USD 15.3 Bn by the year 2034 at a 7.1% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The increas...

View Sample PDF

Cell_Line_Development_Market.JPG

Cell Line Development Market Size, Share & Trends Analysis Report By Source of Cell Lines (Mammalian, Microbial, Insect, Others), By Application (Research and Development, Drug Development, By Company Size (Very Large and Large, Mid-sized, Small), Biologics Type, By Region, And By Segment Forecasts, 2025-2034.

Cell Line Development Market Size is valued at USD 1162.61 Mn in 2024 and is predicted to reach USD 3790.05 Mn by the year 2034 at a 12.6% CAGR during the forecast period for 2025-2034. Cell line development creates highly productive, stable cell li...

View Sample PDF

Continuous_Bioprocessing_Market.JPG

Continuous Bioprocessing Market Size, Share & Trends Analysis Report, By Product (Chromatography Systems & Consumables, Filtration Systems & Devices, Bioreactor, Cell Culture Media & Reagents and Others) By Process (Upstream, Downstream) By Application (Monoclonal Antibodies, Vaccines, Cell & Gene Therapy, Others) By End-user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Contract Research Organizations), By Region, Forecasts, 2025-2034

Continuous Bioprocessing Market Size was valued at USD 304.52 Mn in 2024 and is predicted to reach USD 1901.07 Mn by 2034 at a 20.2% CAGR during the forecast period for 2025-2034. Continuous bioprocessing is a technology utilized in the production...

View Sample PDF

Cell_and_Gene_Therapy_Manufacturing_Quality_Control_(QC)_Market.JPG

Cell and Gene Therapy Manufacturing Quality Control (QC) Market Size, Share & Trends Analysis Report By Component (Equipment & Accessories, Consumables, Others), By Application (Sterility Testing, Purity Testing, Potency Testing, Identity Testing, Others (stability, viability, etc.)), By Process (Upstream Processing, Downstream Processing, Packaging), By End-User (Pharmaceutical & Biotechnology Companies, Contract Manufacturing Organizations), By Region, And By Segment Forecasts, 2025-2034

Cell and Gene Therapy Manufacturing Quality Control (QC) Market Size is valued at USD 2.71 Bn in 2024 and is predicted to reach USD 16.32 Bn by the year 2034 at a 19.8% CAGR during the forecast period for 2025-2034. A crucial element in the produc...

View Sample PDF

Slide2-min_(6)82.JPG

Minimal Residual Disease Market, Share & Trends Analysis Report, By Product (Assay Kits & Reagents, Instruments), By Technology (Polymerase Chain Reaction, Next-Generation Sequencing, Flow Cytometry, Other Technologies), By Application (Hematological Malignancies, Lymphoma, Solid Tumors, Multiple Myeloma, Other Applications), By End User, By Region, and Segment Forecasts, 2025-2034

Global Minimal Residual Disease Market Size is valued at USD 1.4 Bn in 2024 and is predicted to reach USD 4.6 Bn by the year 2034 at a 12.8% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Prec...

View Sample PDF

Slide2-min_(6)53.JPG

Plant-Based Vaccines Market Size, Share & Trends Analysis Distribution by Vaccine Type (Viral Vaccines, Bacterial Vaccines, Parasite & Other Vaccines), Application (Influenza, COVID-19, Veterinary Diseases, Other Infectious Diseases, Therapeutic Vaccines), Source (Tobacco (Nicotiana benthamiana), Cereal Crops (Maize, Rice), Other Plants (Potatoes, Lettuce, Spirulina), Plant Cell Cultures (Carrot, Tobacco)), End-User (Veterinary Sector, Human Healthcare, Research Institutions) and Segment Forecasts, 2025-2034

Global Plant-Based Vaccines Market Size is valued at USD 409.5 Mn in 2024 and is predicted to reach USD 2,161.2 Mn by the year 2034 at an 18.2% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: G...

View Sample PDF

In_vivo_CAR_T-cell_Market.JPG

In vivo CAR T-cell Market Size, Share & Trends Analysis Distribution by Delivery Systems (Lipid Nanoparticles (LNPs), Viral Vectors, Oncolytic Viruses), Targets (Hematological Cancers, Solid Tumors, Non-Oncology) and Segment Forecasts, 2025-2034

In vivo CAR T-cell Market Size is predicted to grow at a 32.9% CAGR during the forecast period for 2025-2034. In vivo CAR T-cell therapy is a promising development in cancer immunotherapy, enabling the genetic modification of a patient’s T c...

View Sample PDF

Slide2-min_(1)2.JPG

Transitional Care Management Services Market Size, Share & Trends Analysis Report By Service(Patient Transitional Care Management Services, Healthcare Transitional Care Management Services, Billing Transitional Care Management Services, Others), By End-Use, By Region, And Segment Forecasts, 2025-2034

Global Transitional Care Management Services Market Size is valued at USD 269.3 Mn in 2024 and is predicted to reach USD 1305.6 Mn by the year 2034 at a 17.2% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from t...

View Sample PDF

Antimicrobial_Peptides_Market_.jpg

Antimicrobial Peptides Market Size, Share & Trends Analysis Report By Product (Plant Antimicrobial Peptides, Bacterial Antimicrobial Peptides, Animal Antimicrobial Peptides, Insect Antimicrobial Peptides), By Ailments, By Route of Administration, By End User, By Distribution Channel, By Region, And By Segment Forecasts, 2025-2034

Antimicrobial Peptides Market Size is valued at USD 248.53 Mn in 2024 and is predicted to reach USD 759.86 Mn by the year 2034 at a 11.9% CAGR during the forecast period for 2025-2034. AMPs possess the ability to eliminate microbial pathogens dire...

View Sample PDF

Categories